Ballentine Partners’s Larimar Therapeutics LRMR Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2024
Q3
Sell
-18,852
Closed -$137K 867
2024
Q2
$137K Buy
+18,852
New +$137K ﹤0.01% 713